Exclusive

Publication

Byline

Location

US Patent Issued to ARCHER-DANIELS-MIDLAND on Sept. 8 for "Oxidative pretreatment of carbohydrate dehydration products comprising humins" (Illinois Inventor)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,187, issued on Sept. 8, was assigned to ARCHER-DANIELS-MIDLAND COMPANY (Decatur, Ill.). "Oxidative pretreatment of carbohydrate dehydration... Read More


US Patent Issued to DSM IP ASSETS on Sept. 8 for "Ring closure of benzoquinones containing an unsaturated side chain using a basic catalyst" (Swiss Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,188, issued on Sept. 8, was assigned to DSM IP ASSETS B.V. (Maastricht, Netherlands). "Ring closure of benzoquinones containing an unsatura... Read More


US Patent Issued to NXERA PHARMA UK on Sept. 8 for "GPR52 modulator compounds" (British Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,189, issued on Sept. 8, was assigned to NXERA PHARMA UK Ltd. (Cambridgeshire, Great Britain). "GPR52 modulator compounds" was invented by S... Read More


US Patent Issued to Baylor College of Medicine on Sept. 8 for "Coronavirus main protease inhibitors and methods using same" (Texas, Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,190, issued on Sept. 8, was assigned to Baylor College of Medicine (Houston). "Coronavirus main protease inhibitors and methods using same"... Read More


US Patent Issued to Eisai R&D Management on Sept. 8 for "Production method for synthetic intermediate of monocyclic pyridine derivative" (Japanese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,191, issued on Sept. 8, was assigned to Eisai R&D Management Co. Ltd. (Tokyo). "Production method for synthetic intermediate of monocyclic ... Read More


US Patent Issued to PHARMABLOCK SCIENCES (NANJING) on Sept. 8 for "CDK9 inhibitor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,192, issued on Sept. 8, was assigned to PHARMABLOCK SCIENCES (NANJING) INC. (Nanjing, China). "CDK9 inhibitor and use thereof" was invented... Read More


US Patent Issued to C4 Therapeutics on Sept. 8 for "Tricyclic ligands for degradation of IKZF2 or IKZF4" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,193, issued on Sept. 8, was assigned to C4 Therapeutics Inc. (Watertown, Mass.). "Tricyclic ligands for degradation of IKZF2 or IKZF4" was ... Read More


US Patent Issued to The Trustees of the University of Pennsylvania, DANA-FARBER CANCER INSTITUTE on Sept. 8 for "Compounds for the treatment of human immunodeficiency virus" (Pennsylvania, Virginia, Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,194, issued on Sept. 8, was assigned to The Trustees of the University of Pennsylvania (Philadelphia) and DANA-FARBER CANCER INSTITUTE (Bost... Read More


US Patent Issued to HitGen on Sept. 8 for "Immunomodulator" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,195, issued on Sept. 8, was assigned to HitGen Inc. (Chengdu, China). "Immunomodulator" was invented by Jin Li (Chengdu, China), Dengyou Zh... Read More


US Patent Issued to AstraZeneca on Sept. 8 for "N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides" (Swedish Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,196, issued on Sept. 8, was assigned to AstraZeneca AB (Sodertalje, Sweden). "N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carbox... Read More